权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Filoviral glycoprotein/cellular protein interactions

丝状病毒糖蛋白/细胞蛋白相互作用

基本信息

批准号：
8645588
负责人：
Wendy Jean Maury
金额：
$ 37.2万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-05-18 至 2015-10-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8645588
关键词：
Africa Antibodies Antigens Antiviral Agents Antiviral Therapy Apical Autopsy Binding Bioinformatics Body Weight decreased CD4 Positive T Lymphocytes Categories Cell Line Cell Surface Receptors Cell surface Cells Comparative Genomic Analysis Complement Cytoplasmic Tail Democratic Republic of the Congo Development Disease Outbreaks Drug or chemical Tissue Distribution Ebola virus Ectopic Expression Endothelial Cells Epithelial Cells Epithelium Family member Filovirus Frankfurt-Marburg Syndrome Virus Future Galactosidase Genes Glycoproteins Helper-Inducer T-Lymphocyte Human Immunoglobulins Immunohistochemistry In Situ Hybridization Infection Iowa Kidney Knock-in Mouse Knock-out Knockout Mice Knowledge Lead Masks Mediating Membrane Proteins Morbidity - disease rate Mucin 1 protein Mucins Mus Pathogenesis Pattern Population Proteins Reporting Respiratory System Respiratory tract structure Role Structure of respiratory epithelium Surface T-Lymphocyte Testing Tissues Tyrosine United States National Institutes of Health Universities Vaccines Viral Hemorrhagic Fevers Viremia Virus Virus Diseases Virus-Cell Membrane Interaction Zoonotic Infection base biodefense design hepatoma cell in vivo mortality mouse model novel public health relevance receptor receptor binding screening transduction efficiency transmission process uptake virus pathogenesis

项目摘要

DESCRIPTION (provided by applicant): The filoviruses Ebola (EBOV) virus and Marburg (MARV) virus are responsible for devastating hemorrhagic fever outbreaks. No vaccines or therapies are currently available against these agents. Because of the high morbidity and mortality associated with infection, these zoonotic viruses have been placed on the NIH Biodefense Category A list. A cellular receptor that binds to and mediates filovirus uptake has not been identified. Identification of such a receptor and elucidation of filoviral glycoprotein (GP)/receptor interactions will facilitate the development of antivirals and enhance knowledge of filoviral pathogenesis. This submission is designed to help fill this knowledge gap. We have identified that the surface protein TIM-1 serves as a cellular receptor for filoviruses on epithelial cells. These studies will elucidate the interactions between human and murine TIM-1 and filovirus glycoproteins that are required for binding and virus entry into endothelial cells. Additionally, our studies to date demonstrated that the expression of TIM-1 within the body is poorly understood. In tissue sections, we will identify cells that express TIM-1 hypothesizing that TIM-1 expression is common on many epithelia. Finally, using a tim-1 knock out mouse, we will determine the impact of Tim-1 on EBOV infection and pathogenesis in the mouse model. In total, these studies will pave the way for the development of future antivirals against these deadly viruses.

描述(申请人提供)：丝状病毒埃博拉病毒(EBOV)和马尔堡病毒(MARV)是毁灭性出血热暴发的罪魁祸首。目前还没有针对这些病原体的疫苗或疗法。由于与感染相关的高发病率和高死亡率，这些人畜共患病毒已被列入美国国立卫生研究院生物防御A类名单。结合并介导丝病毒摄取的细胞受体尚未确定。鉴定这种受体和阐明丝状病毒糖蛋白(GP)/受体的相互作用将有助于抗病毒药物的开发和加强对丝状病毒致病机制的认识。这份报告旨在帮助填补这一知识空白。我们已经确定，表面蛋白TIM-1是上皮细胞上丝状病毒的细胞受体。这些研究将阐明人和鼠TIM-1与丝状病毒糖蛋白之间的相互作用，这些糖蛋白是结合和病毒进入内皮细胞所必需的。此外，到目前为止，我们的研究表明，对TIM-1在体内的表达知之甚少。在组织切片中，我们将识别表达TIM-1的细胞，假设TIM-1表达在许多上皮细胞中是常见的。最后，利用TIM-1基因敲除小鼠，我们将在小鼠模型中确定TIM-1对EBOV感染和发病机制的影响。总而言之，这些研究将为未来开发针对这些致命病毒的抗病毒药物铺平道路。